Médecins pour Cancer du sein à l'étranger — Page 4

Le Prof. Dr Cemil Bilir est un oncologue médical hautement qualifié, membre prestigieux de l'ASCO et de l'ESMO.

• Plus de 15 ans d'expérience en oncologie médicale
• Formé à l'Université Bulent Ecevit et à l'Université Recep Tayyip Erdogan
• Expérience en recherche à l'Université Northeastern aux États-Unis
• Professeur à la Faculté de Médecine de l'Université de Sakarya
• Spécialisé dans le traitement et la recherche sur le cancer du sein

Spécialisée en virothérapie depuis plus de 30 ans – Dr Jaunalksne apporte des approches immunologiques de pointe au traitement du cancer du sein.

• Chef du centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins
• Diplômée de l'Institut médical de Riga avec un internat en médecine interne
• Plus de 30 ans d'expérience dans la recherche et la pratique de l'immunologie

Le Dr Séverine Iborra dirige l'unité de sénologie/clinique du sein au centre mammaire Bergisches de Solingen, se spécialisant dans la prise en charge du cancer du sein avec un accent particulier sur l'oncologie gynécologique.

• Certifiée en diagnostic et thérapie oncologique par le Groupe de travail sur l'oncologie gynécologique
• Qualifications supplémentaires en urogynécologie et en chirurgie reconstructrice pelvienne
• Membre actif des principales sociétés médicales allemandes de gynécologie et d'obstétrique
• Vaste expérience en recherche avec de nombreuses publications en oncologie gynécologique

Le Dr Seyda Gunduz, professeur, est spécialisée en oncologie à l'hôpital universitaire Istinye Liv de Bahcesehir, et se concentre sur les cas de cancer du sein.

• Évaluer et traiter les cas de masses mammaires avec expertise
• Posséder une grande expérience en oncologie avec un diplôme de médecine
• Travailler dans un hôpital universitaire prestigieux

Le professeur Gul Alco est spécialisée dans le traitement du cancer du sein à l'aide de techniques avancées d'oncologie radiothérapique à l'hôpital de district Medipol Acibadem.

• Plus de 20 ans d'expérience en radio-oncologie
• Professeur au département de radio-oncologie de l'université Medipol d'Istanbul
• Formée à l'université d'Istanbul et à l'université Kadir Has
• Ancienne professeure associée à l'université Demiroglu Bilim

Plus de deux décennies d'expertise chirurgicale, y compris une formation avancée en chirurgie oncologique à la Faculté de médecine de Cerrahpaşa.

• Se spécialiser en chirurgie laparoscopique et anti-reflux depuis 2002
• Formation récente en chirurgie laparoscopique avancée et bariatrique
• Exercer aux hôpitaux Büyük Anadolu

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Le Pr. Nail Paksoy apporte une expertise approfondie dans le traitement du cancer du sein, avec une certification de l'ESMO et une participation à des essais cliniques internationaux.

• Se spécialiser dans les traitements du cancer du sein HER2-positif
• Participer activement à des essais oncologiques majeurs, notamment Astefania (ROCHE)
• Recherches publiées sur les résultats du cancer du sein métastatique

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Le Dr Ozden est spécialisé en oncologie médicale avec un accent particulier sur le cancer du sein, apportant des années d'expérience dévouée à l'hôpital VM Medical Park Pendik.

• Formé à la faculté de médecine Cerrahpaşa de l'université d'Istanbul
• Spécialisation en oncologie médicale à l'université de Kocaeli
• Plus d'une décennie d'expérience en médecine interne et en oncologie

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Le Dr Alemdar est spécialisé dans le traitement du cancer du sein, avec une formation approfondie en oncologie médicale à l'université d'Akdeniz.

• Oncologue médical certifié avec plus de 17 ans d'expérience
• Exerce au complexe hospitalier Medical Park Antalya – un centre d'oncologie de premier plan
• Pratique axée sur le diagnostic et le traitement du cancer du sein

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Spécialiste en chirurgie oncoplastique du sein – Le Dr Zengel pratique des mastectomies avec conservation de la peau et du sein avec reconstruction simultanée.

• Plus de 25 ans d'expérience en chirurgie mammaire
• Expert des techniques ROLL et SNOLL pour la localisation précise des tumeurs
• Professeur agrégé de chirurgie générale
• Membre de l'Association des maladies du sein d'Izmir

Le Dr Salman se spécialise dans le traitement du cancer du sein à l'hôpital international Medicalpoint, offrant des soins personnalisés avec un profilage génomique avancé.

• Plus de 15 ans d'expérience en oncologie médicale
• Expert en thérapies ciblées et en immunothérapie pour le cancer du sein
• Membre de l'European Society of Medical Oncology et de l'American Society of Clinical Oncology
• Visiteur académique au Moffitt Cancer Center à Tampa, en Floride

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.